Success Stories: With USCIS’s Premium Processing Service and Our Experienced Team, an Ethiopian Postdoctoral Fellow in Public Health Secures EB1A Approval Within a Week

 

Client’s Testimonial:

“Dear Chen Immigration Team, thank you so much for this great news. I am impressed by the dedication, timely responses, and quality of your work. The entire team deserves a 5-star review. It will be my pleasure to share this success story on your website. Thank you again!”


On February 5th, 2024, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Public Health (Approval Notice).


General Field: Public Health

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Ethiopia

State of Residence at the Time of Filing: Maryland

Approval Notice Date: February 5th, 2024

Processing Time: 7 days (Premium Processing Requested)


Case Summary:

Our client is a well-known public health expert who is also one of the few prominent professionals in psychiatry and mental health. He hired the North America Immigration Law Group to help him secure EB1A approval.

The EB1A (Alien of Extraordinary Ability) category of nonimmigrant visa is reserved for non-Americans with a demonstrated track record of distinction in their field of study. This can be demonstrated through national and worldwide recognition or prizes, as well as support from well-known institutions.

So, we started evaluating his mailed credentials before preparing a petition packet for him and noted that he has achieved a consistent and notable record of success and influence in this area of study and is especially well-known for his investigation into the Global Burden of Disease Study. Furthermore, his work has received funding from such prestigious organizations as the Bill and Melinda Gates Foundation and the African Union (AU). This funding supports projects that contribute research to improve the quality of life for all people. Therefore, our client’s research is apparently important for supporting enhanced public health.

In summary, his analysis holds immense value for reducing the greater disease burden on society at large. His expertise is important for promoting and prolonging good health throughout the lifespan. As a result, we agreed and proceeded with preparing his case, ensuring that we had all the required evidence available to obtain this EB1A approval without any obstacles. This involved reviewing his CV, transcripts, certifications, awards, letters of recommendation, publication and citation history, peer review count, and so on.

We incorporated his published work, which resulted in 86 peer-reviewed journal publications (13 first-authored), demonstrating that his work is highly valued by the editors of the leading journals in the field.

Also, his work has been cited 42,657 times by researchers in at least dozens of countries. Therefore, this affirms that our client has provided independent researchers from around the world with insight critical to a range of advances in the field of public health.

Besides, he has conducted at least 11 reviews for highly acclaimed journals. In addition to his work as a peer reviewer, he sits on the editorial board of Reproductive Health, further demonstrating that he satisfies this criterion.

Furthermore, his authority in the field has been further acknowledged by the Center for Effective Global Action, which has enlisted him to review submitted grant applications and determine which applications merit the receipt of highly selective funding based on their pioneering proposals and their relevance to addressing the most pressing needs of the field. he has conducted 19 grant reviews in total.

After analyzing these documents, our team discovered substantial proof that his work has a significant impact on some of our nation’s and the world’s most pressing issues, including psychiatric and mental health problems of children, adolescents, and parents.

Therefore, these recurring results in his previous work suggest that our client’s work is dedicated to advances in public health, which are matters of critical national importance. Researchers like him are highly skilled in this field and are thus crucial to the United States. When the approval came through in February of 2024, just 7 days after the premium processing service upgrade, we could only rejoice at our client's achievement. We appreciate his ongoing trust in us and look forward to further assisting him.